Concepedia

Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial

Thomas Vanassche, Peter Verhamme, Philip S. Wells, Annelise Segers, Walter Ageno, Marjolein Brekelmans, Cathy Z. Chen, Alexander T. Cohen, Michael Grosso, Andria Medina,

Thrombosis Research · 2017 · 31 citations · 16 references

DOI

Concepts

References

16

Antithrombotic Therapy for VTE Disease

Clive Kearon, Elie A. Akl, Joseph Ornelas et al. · CHEST Journal · 2016 · 4.8K citations

, , +12

A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy

F.R. Rosendaal, Suzanne C. Cannegieter, F.J.M. van der Meer et al. · Thrombosis and Haemostasis · 1993 · 2.1K citations · Full text

, , +14

Edoxaban versus Warfarin for the Treatment of Symptomatic Venous Thromboembolism

New England Journal of Medicine · 2013 · 1.9K citations · Full text

, , +13

Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

Jonathan L. Halperin, Graeme J. Hankey, Daniel Wojdyla et al. · Circulation · 2014 · 429 citations · Full text

, , +17

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial

Sigrun Halvorsen, Dan Atar, H. Yang et al. · European Heart Journal · 2014 · 368 citations · Full text

, , +17